Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FWKRL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,669
Award facts
- Contract value 100% obligated
- $12,668.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $12,668.89 delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The DLA Troop Support Medical IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse medical commodity requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Zepbound, a GLP-1 receptor agonist approved for weight management, represents part of the company's ongoing portfolio of specialty medications delivered through the federal supply chain to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FWKRL?
SPE2DB25FWKRL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FWKRL worth?
The government has obligated $12,669 on SPE2DB25FWKRL.
Is contract SPE2DB25FWKRL an order under another contract?
Yes. SPE2DB25FWKRL is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKRL competed?
The extent of competition for SPE2DB25FWKRL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award